[SLRX] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 31.74%
YoY- 60.21%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 1,378 875 251 -
PBT -972 -2,443 -14,409 -3,737 -1,717 -2,630 -2,638 -15.31%
Tax 0 -89 -78 -10 -42 -2 0 -
NP -972 -2,443 -14,331 -3,737 -1,717 -2,628 -2,638 -15.31%
Tax Rate - - - - - - - -
Total Cost 972 2,443 14,331 3,737 3,095 3,503 2,889 -16.58%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 -124.55 -300.33 -1,051.18 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.76 -0.65 -6.38 -2.09 -2.39 -18.22 -91.27 -54.94%
EPS Diluted -0.76 -0.65 -6.38 -2.09 -2.39 -18.22 -91.27 -54.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.